New Zealand markets closed

Takeda Pharmaceutical Company Limited (TAK)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
14.07+0.05 (+0.36%)
At close: 4:00PM EDT
14.10 +0.03 (+0.21%)
After hours: 07:40PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close14.02
Bid13.95 x 3000
Ask14.11 x 2900
Day's range13.97 - 14.10
52-week range13.91 - 19.97
Avg. volume2,182,329
Market cap44.251B
Beta (5Y monthly)1.10
PE ratio (TTM)11.76
Earnings dateN/A
Forward dividend & yield0.84 (5.97%)
Ex-dividend date30 Mar 2021
1y target estN/A
  • Zacks

    Seagen's (SGEN) Cancer Portfolio Strong, Stiff Rivalry a Worry

    Seagen (SGEN) focuses on improving sales of its marketed drugs that are approved for different types of cancer indications. Stiff competition in the target market remains a woe.

  • Motley Fool

    Why Takeda Pharmaceutical Stock Is Down More Than 10% Today

    The prescription drugmaker is halting a trial before a scheduled stopping point, suggesting it's too dangerous to expect an approval.

  • Bloomberg

    Japan Moderna Supplier Takeda Plans Its Second-Biggest Yen Bond

    (Bloomberg) -- Takeda Pharmaceutical Co., a drugmaker that distributes Moderna Inc.’s vaccine in Japan, is planning what would be its second-biggest yen bond sale ever next week.The Tokyo-based company is scheduled to price a 200 billion yen ($1.8 billion) 10-year note on Oct. 8, and intends to use the funds to refinance its existing debt, according to underwriter SMBC Nikko Securities Inc. That would be its largest Japanese-currency sale after a jumbo 500 billion yen offering in 2019 to help pa